Intradiscal Autologous Biologics for the Treatment of Chronic Discogenic Low Back Pain
Current Pain and Headache Reports · 2024
DOI: 10.1007/s11916-024-01294-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Pain and Headache Reports, 2024. Verfasst von Wisdom Ufondu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Program in Liberal Medical Education (PLME), Brown University, Providence, RI, USA. Hauptthemen laut MEDLINE: Low Back Pain, Biological Products, Intervertebral Disc Degeneration. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
PURPOSE OF REVIEW: The purpose of this narrative review is to evaluate the efficacy of the most commonly studied intradiscal biologics used for the treatment and alleviation of chronic intractable discogenic low back pain. Additionally, it explores the therapeutic potential and durability of these novel treatment options. RECENT FINDINGS: Recently published literature highlights the therapeutic potential of intradiscal biologics, such as mesenchymal stem cells, platelet-rich plasma, and alpha-2-macroglobulin, in promoting chondrogenesis within the lumbar intervertebral discs to treat discogenic low back pain. Studies demonstrate significant improvements in pain relief, physical function, and quality of life post-treatment. A comprehensive review of the literature evaluating the efficacy of intradiscal biologics suggests some evidence supporting its efficacy in treating discogenic low back pain. However, more rigorous studies into mechanistic modulation and large-scale randomized trials as well as a more thorough understanding of adverse events will be instrumental for including these therapies into clinical practice paradigms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Program in Liberal Medical Education (PLME), Brown University, Providence, RI, USA.
- Beth Israel Deaconess Medical Center, Department of Anesthesiology, Critical Care and Pain Medicine, Harvard Medical School, Boston, MA, USA.
- Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
- Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
- Department of Orthopedic Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
- Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, MD, USA.
Zitieren
APA
Ufondu, W., Robinson, C. L., Hussain, N., D'Souza, R. S., Karri, J., Emerick, T., & Orhurhu, V. J. (2024). Intradiscal Autologous Biologics for the Treatment of Chronic Discogenic Low Back Pain. Current Pain and Headache Reports. https://doi.org/10.1007/s11916-024-01294-8
Vancouver
Ufondu W, Robinson CL, Hussain N, D'Souza RS, Karri J, Emerick T, et al. Intradiscal Autologous Biologics for the Treatment of Chronic Discogenic Low Back Pain. Current Pain and Headache Reports. 2024. doi:10.1007/s11916-024-01294-8
BibTeX
@article{Ufondu2024,
author = {Ufondu, Wisdom and Robinson, Christopher L and Hussain, Nasir and D'Souza, Ryan S and Karri, Jay and Emerick, Trent and Orhurhu, Vwaire J},
title = {Intradiscal Autologous Biologics for the Treatment of Chronic Discogenic Low Back Pain},
journal = {Current Pain and Headache Reports},
year = {2024},
doi = {10.1007/s11916-024-01294-8}
}
EUVIMED